← Back to headlines
Dassault Systèmes Reportedly in Talks to Acquire ArisGlobal for $2 Billion
Dassault Systèmes is reportedly in discussions to acquire ArisGlobal, a drug trial software company, for approximately $2 billion. The potential acquisition was reported by the Financial Times.
16 Jul, 18:12 — 16 Jul, 19:14
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (46/100)3 sources25/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left
Center1
Center (1)
FT
Right2
Right (2)
seeking-alphachannel-news-asia
Far R
Geographic diversity— 3 regions13/34
US1Singapore1UK1
Sources
Showing 2 of 3 sources
FTVery High31d ago
Dassault Systèmes in talks to buy drug trial software company for about $2bn
Potential purchase of ArisGlobal from Swedish buyout group would boost French conglomerate’s push into life sciences
Read full article →seeking-alphaMixed31d ago
Dassault Systèmes in talks to buy drug trial software company for $2B - FT
Read full article →Coverage Timeline
First report: FT · 16 Jul, 18:12|Full coverage: 3 · 1h|Window: 1h
Left-leaningCenterRight-leaning
